QuiVad

Home / Germany / Circassia Pharmaceuticals PLC

Circassia Pharmaceuticals PLC

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 5.42% on November 7, 2017. The shaded band is the year shown above.

July 29, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

Follow by RSS

Get the moves on Circassia Pharmaceuticals PLC by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

61 disclosures on record for this share.
DateFund% of capitalEnd of publication
March 6, 2020Squarepoint OPS LLC0.40%
March 4, 2020Squarepoint OPS LLC0.59%
March 3, 2020Squarepoint OPS LLC0.69%
February 24, 2020Squarepoint OPS LLC0.83%
February 17, 2020Squarepoint OPS LLC0.70%
February 12, 2020Squarepoint OPS LLC0.60%
February 10, 2020Squarepoint OPS LLC0.53%
June 3, 2019THE Mangrove Partners Master Fund, LTD.0.00%
May 16, 2019THE Mangrove Partners Master Fund, LTD.2.39%
November 7, 2017THE Mangrove Partners Master Fund, LTD.5.42%
October 11, 2017THE Mangrove Partners Master Fund, LTD.5.32%
September 15, 2017THE Mangrove Partners Master Fund, LTD.4.91%
September 8, 2017THE Mangrove Partners Master Fund, LTD.4.79%
June 22, 2017THE Mangrove Partners Master Fund, LTD.4.65%
June 21, 2017THE Mangrove Partners Master Fund, LTD.4.45%
June 16, 2017THE Mangrove Partners Master Fund, LTD.3.97%
June 15, 2017THE Mangrove Partners Master Fund, LTD.3.85%
June 9, 2017THE Mangrove Partners Master Fund, LTD.3.73%
June 1, 2017THE Mangrove Partners Master Fund, LTD.3.63%
May 9, 2017THE Mangrove Partners Master Fund, LTD.3.53%
May 4, 2017THE Mangrove Partners Master Fund, LTD.3.44%
April 28, 2017THE Mangrove Partners Master Fund, LTD.3.27%
April 18, 2017THE Mangrove Partners Master Fund, LTD.3.74%
April 13, 2017THE Mangrove Partners Master Fund, LTD.3.53%
April 3, 2017THE Mangrove Partners Master Fund, LTD.2.46%
March 24, 2017THE Mangrove Partners Master Fund, LTD.2.33%
March 20, 2017THE Mangrove Partners Master Fund, LTD.2.04%
October 14, 2016GSA Capital Partners LLP0.49%
September 20, 2016GSA Capital Partners LLP0.59%
August 18, 2016GSA Capital Partners LLP0.61%
August 16, 2016THE Mangrove Partners Master Fund, LTD.1.91%
August 8, 2016THE Mangrove Partners Master Fund, LTD.1.81%
July 29, 2016THE Mangrove Partners Master Fund, LTD.1.71%
July 29, 2016GSA Capital Partners LLP0.51%
July 27, 2016THE Mangrove Partners Master Fund, LTD.1.66%
July 19, 2016THE Mangrove Partners Master Fund, LTD.1.52%
July 14, 2016THE Mangrove Partners Master Fund, LTD.1.42%
July 11, 2016THE Mangrove Partners Master Fund, LTD.1.32%
May 5, 2016THE Mangrove Partners Master Fund, LTD.1.25%
April 4, 2016THE Mangrove Partners Master Fund, LTD.1.11%
March 31, 2016THE Mangrove Partners Master Fund, LTD.1.05%
March 23, 2016THE Mangrove Partners Master Fund, LTD.0.93%
March 22, 2016THE Mangrove Partners Master Fund, LTD.0.84%
March 21, 2016THE Mangrove Partners Master Fund, LTD.0.64%
March 17, 2016THE Mangrove Partners Master Fund, LTD.0.57%
February 27, 2015Alphagen Capital Limited0.00%
February 10, 2015Schroder Investment Management Limited0.00%
January 26, 2015Alphagen Capital Limited0.60%
January 13, 2015Alphagen Capital Limited0.56%
December 15, 2014Alphagen Capital Limited0.72%

Download 61 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Circassia Pharmaceuticals PLC, source Bundesanzeiger, data as at March 6, 2020, https://www.quivad.com/action/circassia-pharmaceuticals-plc